HDAC9 and HIV-1 infection: We therefore measured the combined direct and indirect effect of HDAC inhibitors on HERV expression in J-LAT8.4 and U1 cells, which are models of HIV-1 latency in cell types that are subject to HIV-1 infection in vivo.